Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Chuleeporn, Jiarpinitnun"'
Autor:
Pasvich Pitakpaiboonkul, Chuleeporn Jiarpinitnun, Poompis Pattaranutaporn, Nuttapong Ngamphaiboon
Publikováno v:
Cancer Medicine, Vol 13, Iss 4, Pp n/a-n/a (2024)
Abstract Background R/M‐HNSCC patients typically receive 1L platinum‐based chemotherapy with pembrolizumab or cetuximab. However, the outcomes for patients with early recurrence (12 months, and de novo metastasis, respectively. The platinum‐bas
Externí odkaz:
https://doaj.org/article/1dfbb15a5344451ab0121c1c727af25b
Autor:
Nuttapong Ngamphaiboon, Arunee Dechaphunkul, Jiraporn Setakornnukul, Tanadech Dechaphunkul, Rungarun Jiratrachu, Bhoom Suktitipat, Chuleeporn Jiarpinitnun, Poompis Pattaranutaporn, Pongwut Danchaivijitr
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Chemoradiotherapy (CRT) with high cumulative doses (CDs) of cisplatin has been considered the standard of care for non-metastatic nasopharyngeal carcinoma (NPC). However, given most patients’ inability to tolerate high CDs due t
Externí odkaz:
https://doaj.org/article/579256eb56944e2c969acb113232ee16
Autor:
Chanon Puttanawarut, Nat Sirirutbunkajorn, Narisara Tawong, Chuleeporn Jiarpinitnun, Suphalak Khachonkham, Poompis Pattaranutaporn, Yodchanan Wongsawat
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeThe aim was to investigate the advantages of dosiomic and radiomic features over traditional dose-volume histogram (DVH) features for predicting the development of radiation pneumonitis (RP), to validate the generalizability of dosiomic and ra
Externí odkaz:
https://doaj.org/article/3a4ac9290e764491811e2f20840fcd5b
Autor:
Jirapath, Wiwitkeyoonwong, Chuleeporn, Jiarpinitnun, Pitichote, Hiranyatheb, Nuttapong, Ngamphaiboon
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 22:3847-3855
Malnutrition and weight loss are commonly observed in patient with esophageal and esophagogastric junction (EGJ) cancers. Chemoradiotherapy (CRT) is a mainstay of treatment for locally advanced esophageal and EGJ cancers. Impact of weight loss on pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9dbc18d4ef4593788189fece27d309e4
https://doi.org/10.31557/apjcp.2021.22.12.3847
https://doi.org/10.31557/apjcp.2021.22.12.3847
Autor:
P. Pattaranutaporn, Tanadech Dechaphunkul, Jiraporn Setakornnukul, Nuttapong Ngamphaiboon, Chuleeporn Jiarpinitnun, Rungarun Jiratrachu, Bhoom Suktitipat, P. Danchaivijitr, Arunee Dechaphunkul
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
BMC Cancer
BMC Cancer
Background Chemoradiotherapy (CRT) with high cumulative doses (CDs) of cisplatin has been considered the standard of care for non-metastatic nasopharyngeal carcinoma (NPC). However, given most patients’ inability to tolerate high CDs due to cisplat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23cdb43d55899705f6770974eb5ce9d8
http://link.springer.com/article/10.1186/s12885-020-07024-8
http://link.springer.com/article/10.1186/s12885-020-07024-8
Autor:
Tanadech Dechaphunkul, Nuttapong Ngamphaiboon, Pongwut Danchaivijitr, Rungarun Jiratrachu, Sarayut Lucien Geater, Poompis Pattaranutaporn, Chuleeporn Jiarpinitnun, Jiraporn Setakornnukul, Bhoom Suktitipat, Arunee Dechaphunkul
Publikováno v:
American journal of otolaryngology. 43(2)
Prophylactic percutaneous endoscopic gastrostomy (PPEG) is widely used for patients with head and neck cancer undergoing concurrent chemoradiation (CCRT). Nevertheless, the necessity of its use in patients with nasopharyngeal cancer (NPC) is uncertai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8312f9f45b5d7420b73a786fc454d38b
https://pubmed.ncbi.nlm.nih.gov/34972008
https://pubmed.ncbi.nlm.nih.gov/34972008
Autor:
Arunee Dechaphunkul, Pongwut Danchaivijitr, Rungarun Jiratrachu, Tanadech Dechaphunkul, Chatsuda Sookthon, Chuleeporn Jiarpinitnun, Chatchanok Paoin, Jiraporn Setakornnukul, Bhoom Suktitipat, Poompis Pattaranutaporn, Nuttapong Ngamphaiboon
Publikováno v:
Asia-Pacific journal of clinical oncologyREFERENCES.
Though concurrent chemoradiotherapy (CCRT) with cisplatin remains a standard of care for patients with locally advanced nasopharyngeal carcinoma (LA-NPC), carboplatin has alternatively been used without sufficient supportive evidences. Thus, we evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be28c215f55f50b0ab60866e89c4ae92
https://pubmed.ncbi.nlm.nih.gov/35394108
https://pubmed.ncbi.nlm.nih.gov/35394108
Autor:
Sherif Abdelwahab, Brian O'Sullivan, Kada Boualga, Angela Camacho, Chiraz Nasr Ben Ammar, Chuleeporn Jiarpinitnun, Eduardo Zubizaretta, Shengzi Wang, Mohammad Faheem, Kirsten Hopkins, Eduardo Rosenblatt, Arie Munandar, Sarbani Ghosh Laskar, Horace C.W. Choi, Jiraporn Setakornnukul, Noureddine Benjaafar, June Corry, Wai Tong Ng, Ben Prajogi, Alisha Moore, Feng Jin, Yungan Tao, P.N. Hiep, Kiattisa Sommat, Rubina Ali, Nancy Y. Lee, Sofee Holmes, Q.T. Le, Anne W.M. Lee
Publikováno v:
International journal of radiation oncology, biology, physics. 111(5)
Purpose Most new nasopharyngeal cancer cases occur in low-income and middle-income countries, and these patients experience poorer overall survival than that of new nasopharyngeal cancer cases in high-income countries. The goal of this research proje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97c70f5e48119b4cd451775dc62cccb3
https://pubmed.ncbi.nlm.nih.gov/34418466
https://pubmed.ncbi.nlm.nih.gov/34418466
Autor:
Nuttapong Ngamphaiboon, Arunee Dechaphunkul, Jiraporn Setakornnukul, Tanadech Dechaphunkul, Rungarun Jiratrachu, Bhoom Suktitipat, Chuleeporn Jiarpinitnun, Poompis Pattaranutaporn, Pongwut Danchaivijitr
IntroductionChemoradiotherapy (CRT) with high cumulative doses (CDs) of cisplatin has been considered the standard of care for locally advanced nasopharyngeal carcinoma (LA-NPC). However, given most patients’ inability to tolerate high CDs due to c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fb52fcb0eca8bf6ea98193c7e58df87
https://doi.org/10.21203/rs.3.rs-25252/v1
https://doi.org/10.21203/rs.3.rs-25252/v1
Autor:
Tanadech Dechaphunkul, Sarayuth Lucien Geater, Rungarun Jiratrachu, Chudchanok Paoin, Nuttapong Ngaimphaiboon, Arunee Dechaphunkul, P. Pattaranutaporn, Chuleeporn Jiarpinitnun, Jiraporn Setakornnukul, P. Danchaivijitr, Bhoom Suktitipat, Chatsuda Sookthon
BackgroundAlthough concurrent chemoradiotherapy (CCRT) with high-dose cisplatin remains a standard of care for patients with locally advanced nasopharyngeal carcinoma (LA-NPC), carboplatin has alternatively been used, particularly for cisplatin-ineli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f8b8a64075ac2951d33d19626c57aab
https://doi.org/10.21203/rs.2.19749/v2
https://doi.org/10.21203/rs.2.19749/v2